Navigation Links
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Date:4/29/2009

s, all of which involve a number of risks and uncertainties, such as risks associated with preclinical and clinical development of Regeneron's drug candidates, determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize its product and drug candidates, competing drugs that are superior to Regeneron's product and drug candidates, uncertainty of market acceptance of Regeneron's product and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any collaboration agreement, including Regeneron's agreements with the sanofi-aventis Group and Bayer HealthCare, to be canceled or to terminate without any product success, risks associated with third party intellectual property, and other material risks. A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission (SEC), including its Form 10-K for the year ended December 31, 2008. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise unless required by law.


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.; Bayer HealthCare AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
2. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
3. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
4. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
5. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
6. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
7. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
8. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
9. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
10. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
11. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The intravenous ...
(Date:8/22/2014)... N.Y. , Aug. 22, 2014  Mark ... tomography (CT) imaging facility, is using the online ... and even 5D imaging to researchers and would-be ... launched, asks "What would YOU do if you ... possibility to researchers and explorers everywhere, from elementary ...
(Date:8/22/2014)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a ... technologies and products for advanced microarray diagnostics, today ... Service Agreement to contract with a UK-based company ... the initial phase of this agreement, SQI will ... of one of the customer,s assays, operational on ...
Breaking Medicine Technology:Global and Chinese Intravenous Catheter Industry Report 2014 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... MELVILLE, N.Y., Dec. 10, 2010 For the 12th ... ), the largest provider of health care products and ... more than 1,000 children and their families through the ... Henry Schein,s Holiday Cheer program is a flagship initiative ...
... WASHINGTON, Dec. 10, 2010  The Office of Inspector General ... OIG) announced today that Miami resident Yader A. Padilla, 59, ... 2010, by the Honorable U.S. District Judge Paul C. Huck ...  He was sentenced for his role in defrauding the Ex-Im ...
Cached Medicine Technology:Henry Schein's 12th Annual Holiday Cheer For Children Program Encourages Volunteerism and Giving Among Team Schein Members 2Distributed by the Export-Import Bank of the United States On Behalf of the Independent Office of Inspector General 2
(Date:8/22/2014)... 2014 Millennium Treatment Group has recently noticed ... high level of drug use among teenagers. The treatment facility ... addiction and work to minimize drug abuse. , America is ... drug addiction in history. According to the National Institute ... Americans aged 12 or older—or 9.2 percent of the population—had ...
(Date:8/22/2014)... The regional economy is about to ... on the grow again. The plant will invest ... to boost production of the popular Highlander midsize sport ... investment to $4 billion. This step allows Toyota to ... flexibility to adjust its product mix to meet changing ...
(Date:8/22/2014)... team has found that targeted automated alerts in ... in hospital patients with urinary catheters. In addition, ... the rate of improvement dramatically increased. , The ... urinary catheters in the first place and then ... that have not been removed within a recommended ...
(Date:8/22/2014)... Many Americans know little about how Ebola is transmitted and ... the United States, a new survey shows. About four ... be a major Ebola outbreak in the United States, and ... will get sick with the deadly virus in the next ... poll. However, those opinions don,t match reality, the Harvard ...
(Date:8/22/2014)... Lake Worth, FL (PRWEB) August 22, 2014 ... alcohol addiction treatment facility in Lantana, FL, recently ... or those just looking for information can now ... , Millennium’s new website just went live at ... to know about the facility can be found ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Millennium Treatment Group Has a New Website 2
... Whether or not relatives talk about the familys history ... counseling and testing for those at moderate risk of ... presented today at the American Society for Preventive Oncology ... that African Americans participate less often in genetic counseling ...
... in March 2008. Appearing three times a year, it will ... issues in the sciences of the mind. Springer will ... articles during 2008 and 2009. , Neuroethics will be an ... neuroscience of ethics. The journal will be highly inclusive ...
... nogo receptor are offering fresh ways to think about ... reducing the nogo receptor in the brain results in ... between the synapses, the connections between nerve cells in ... central to the brains ability to rewire, a process ...
... CHAPEL HILL, N.C., March 18 Leadership authority ... is critical to,appoint the right leader to help ... both the centralized and decentralized market research,groups -- ... to,control and coordinate operational resources and activities across ...
... Inc.,("Transition" or the "Company") (TSX: TTH, NASDAQ:TTHI) today ... Officer, will present at,the upcoming Cowen & Company ... take place on Wednesday, March 19, 2008 at ... Place., About Transition, ----------------, Transition ...
... metabolic disorder, which is associated with intracellular copper ... in Wilson,s disease include arrhythmias and cardiac failure. ... and in Ankara University Faculty of Medicine investigated ... of intra-atrial conduction disturbance in patients with Wilson,s ...
Cached Medicine News:Health News:Family communication impacts attitude about genetic counseling/testing for breast cancer 2Health News:Springer to publish new journal focusing on ethical issues in neuroscience 2Health News:Stopping a receptor called 'nogo' boosts the synapses 2Health News:Stopping a receptor called 'nogo' boosts the synapses 3Health News:Stopping a receptor called 'nogo' boosts the synapses 4Health News:Create Strong Leadership to Add Value to Market Research Function 2Health News:Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference 2Health News:How does P wave dispersion change in patients with Wilson's disease? 2
Custom-made chisels....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
Medicine Products: